95 related articles for article (PubMed ID: 18061126)
1. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells.
Roth S; Langguth P; Spicher K; Enzmann H
Transl Res; 2008 Jan; 151(1):36-44. PubMed ID: 18061126
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
[TBL] [Abstract][Full Text] [Related]
3. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
Zager RA; Johnson AC; Hanson SY
Kidney Int; 2004 Jul; 66(1):144-56. PubMed ID: 15200421
[TBL] [Abstract][Full Text] [Related]
4. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
Schnorr J; Fütterer S; Spicher K; Catarinolo M; Schlösser C; Enzmann H; Langguth P
Regul Toxicol Pharmacol; 2018 Apr; 94():293-298. PubMed ID: 29454888
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
Toblli JE; Cao G; Oliveri L; Angerosa M
Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
[TBL] [Abstract][Full Text] [Related]
7. [Effects of carbon-coated iron nanocrystals combined with epirubicin on HepG-2 cells and its acute toxicity in mice].
Zheng Y; Lao XM; Zhang HY; Chen YM; Chen MS; Yuan YF; Zhang YQ; Li JQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):176-9. PubMed ID: 18250036
[TBL] [Abstract][Full Text] [Related]
8. Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats.
Kudo H; Suzuki S; Watanabe A; Kikuchi H; Sassa S; Sakamoto S
Toxicology; 2008 Apr; 246(2-3):143-7. PubMed ID: 18289763
[TBL] [Abstract][Full Text] [Related]
9. In ovo carcinogenicity assay (IOCA): evaluation of mannitol, caprolactam and nitrosoproline.
Brunnemann KD; Enzmann HG; Perrone CE; Iatropoulos MJ; Williams GM
Arch Toxicol; 2002 Oct; 76(10):606-12. PubMed ID: 12373457
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and toxicological characterization of a new generic iron sucrose preparation.
Meier T; Schropp P; Pater C; Leoni AL; Khov-Tran VV; Elford P
Arzneimittelforschung; 2011; 61(2):112-9. PubMed ID: 21428246
[TBL] [Abstract][Full Text] [Related]
11. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers.
Ma HL; Xu YF; Qi XR; Maitani Y; Nagai T
Int J Pharm; 2008 Apr; 354(1-2):217-26. PubMed ID: 18191350
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
[TBL] [Abstract][Full Text] [Related]
13. [Dextran-ferrite distribution in the body of animals in a nonuniform permanent magnetic field].
Syrkin AB; Iushkov SF; Bulychev IuN; Brusentsov NA; Osipov NE; Karamanov SA; Kolesnikova EIu
Eksp Onkol; 1990; 12(5):71-3. PubMed ID: 2226266
[TBL] [Abstract][Full Text] [Related]
14. Agglomeration of tungsten carbide nanoparticles in exposure medium does not prevent uptake and toxicity toward a rainbow trout gill cell line.
Kühnel D; Busch W; Meissner T; Springer A; Potthoff A; Richter V; Gelinsky M; Scholz S; Schirmer K
Aquat Toxicol; 2009 Jun; 93(2-3):91-9. PubMed ID: 19439373
[TBL] [Abstract][Full Text] [Related]
15. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury.
Zager RA; Johnson AC; Hanson SY; Wasse H
Am J Kidney Dis; 2002 Jul; 40(1):90-103. PubMed ID: 12087566
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines.
Martin AL; Bernas LM; Rutt BK; Foster PJ; Gillies ER
Bioconjug Chem; 2008 Dec; 19(12):2375-84. PubMed ID: 19053308
[TBL] [Abstract][Full Text] [Related]
17. In vitro toxicity testing of nanoparticles in 3D cell culture.
Lee J; Lilly GD; Doty RC; Podsiadlo P; Kotov NA
Small; 2009 May; 5(10):1213-21. PubMed ID: 19263430
[TBL] [Abstract][Full Text] [Related]
18. Cell toxicity of superparamagnetic iron oxide nanoparticles.
Mahmoudi M; Simchi A; Milani AS; Stroeve P
J Colloid Interface Sci; 2009 Aug; 336(2):510-8. PubMed ID: 19476952
[TBL] [Abstract][Full Text] [Related]
19. Contribution of mesothelium-derived cells to liver sinusoids in avian embryos.
Pérez-Pomares JM; Carmona R; González-Iriarte M; Macías D; Guadix JA; Muñoz-Chápuli R
Dev Dyn; 2004 Mar; 229(3):465-74. PubMed ID: 14991702
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study.
Pai AB; Norenberg J; Boyd A; Raj D; Chan LN
Clin Ther; 2007 Dec; 29(12):2699-705. PubMed ID: 18201586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
